DCA Officials Seize ‘Diclojan Forte’ Tab For Misleading Claims

HYDERABAD: Officials of Drugs Control Administration, Telangana seized ‘DICLOJAN Forte Tablets (Diclofenac Sodium & Paracetamol Tablets),’ in Aiza Village, Jogulamba-Gadwal District, for making a misleading advertisement claiming it treats ‘fever.

In a statement here on Thursday, DCA Director-General VB Kamalasan Reddy said that the officials detected a medicine ‘DICLOJAN Forte Tablets’ circulating in the market with misleading claim on its label that it treats ‘fever’, which is a contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. During the special raids conducted on 24th, and 25th April, officials from the Drugs Control Administration, Mahabubnagar Zone, detected ‘DICLOJAN Forte Tablets’. The said medicine was detected by DCA officials at a medical shop situated in Aiza Village, Aiza Mandal, Jogulamba-Gadwal District. Stocks were seized during the raid.

The advertisement of a medicine for the treatment of ‘fever’ in general is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Mohd. Rafhi Shaik, Drugs Inspector, Gadwal and A.N. Kranthi Kumar, Drugs Inspector, Narayanpet are among the officers who carried out the raid. Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

Persons who make misleading advertisements regarding drugs for treatment of certain diseases and disorders are punishable under Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, with imprisonment which may extend to six months, or with fine, or with both.

The public may report any complaints regarding illegal activities concerning medicines through the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.

Related Posts

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

Shimla: The National Green Tribunal (NGT) has issued notice to a pharmaceutical manufacturing unit in Himachal Pradesh over allegations of environmental norm violations, including noise pollution, discharge of untreated or…

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

Lucknow:  As Uttar Pradesh intensifies efforts to achieve its ambitious $1 trillion economy target, the Yogi Adityanath government is steadily expanding its focus beyond traditional manufacturing and services by aggressively…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

NGT issues notice to Himachal pharma unit over pollution, water diversion allegations

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports

DGFT Fixes Six New Standard Input Output Norms (SIONs) for Pharmaceutical and Chemical Exports

Nurse, another arrested in ASHA worker’s death at illegal hospital; main accused at large

Nurse, another arrested in ASHA worker’s death at illegal hospital; main accused at large

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

Haryana Launches ‘Make in Haryana Industrial Policy’

Haryana Launches ‘Make in Haryana Industrial Policy’